Pomona, New York — June 27, 2025 — NeuroLight, Inc., a pioneering neurotechnology company developing breakthrough solutions for sleep disorders and neurological conditions, today announced the appointment of Manish Vaishya, Ph.D., to its Advisory Board.
NeuroLight is transforming the treatment of neurological conditions through its patented technology for transplanting brain states, which enables the replication of optimal neural patterns from healthy individuals to those suffering from various disorders. The company’s innovative approach shows significant promise for treating insomnia, preventing Alzheimer’s disease, managing Parkinson’s symptoms, addressing PTSD, combating memory deterioration, and enhancing overall cognitive performance.
Dr. Manish Vaishya brings over 20 years of experience in medical device development and commercialization. He holds a Ph.D. in Mechanical and Systems Engineering and has served as Chief Technical Officer for multiple successful MedTech companies, leading the development of FDA-approved devices in neuromodulation, cochlear implants, class II and class III systems and digital health. His expertise spans R&D, product development, manufacturing operations, regulatory strategy, clinical trial design, and go-to-market execution.
“Dr. Vaishya’s exceptional track record in bringing innovative medical devices from concept to market makes him an invaluable addition to our Advisory Board,” said Alexander Poltorak, Founder and President of NeuroLight. “His deep understanding of neuromodulation technologies and regulatory pathways will be instrumental as we advance our NeuroMask™ platform through clinical trials and toward commercialization.”
“I am thrilled to join NeuroLight at this pivotal moment in the company’s journey,” said Dr. Vaishya. “The potential of brain state transfer technology to address the global crisis of sleep disorders and neurodegenerative diseases is truly transformative. NeuroLight’s approach, backed by a broad patent portfolio, represents a paradigm shift in how we think about treating neurological conditions. I look forward to contributing to the development of solutions that will improve millions of lives worldwide.” NeuroLight’s flagship product, NeuroMask™—a smart sleep mask—uses non-invasive sensory stimulation combining precisely modulated light and sound patterns to induce desired states of sleep (e.g., N3, SWS or REM) or other brain states (flow states, relaxation state, pick performance state, etc.). The technology addresses chronic sleep issues affecting over 70 million Americans while offering broader applications for cognitive enhancement and neurological disease management.
